Dr. Mannan Nouri is an Instructor in Medicine at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, where he specializes in the molecular mechanisms of prostate cancer. He joined BIDMC as a Research Fellow in 2019 after earning his PhD in Oncology from the University of British Columbia, where his doctoral research at the Vancouver Prostate Centre focused on targeting cancer stem cells and developing therapies to eliminate treatment-resistant tumor populations.
Currently, Dr. Nouri is a member of the Balk Lab, at the Dana Farber Harvard Cancer Center (DF/HCC), where his scientific interests center on identifying novel vulnerabilities in Androgen Receptor (AR) variant-driven prostate cancer. His work explores the intersection of genetics, genomics, and cellular reprogramming, specifically investigating how cancer cells adapt to survive androgen-targeted therapies.
In addition to his research, Dr. Nouri is actively involved in medical education, teaching genetics, genomics and evolution to students at Harvard University, and mentoring undergraduate students during the summer with the DF/HCC Continuing Umbrella of Research Experiences (CURE) program.